Drug- and patient-specific neurological risk profiles of α1-adrenergic blockers: evidence from FAERS and external validation in JADER. [PDF]
Hai X, Huang L.
europepmc +1 more source
Chemical Motifs Associated with FAERS-Derived Severe Cutaneous Adverse Reaction Disproportionality Signals: An Interpretable Pharmacovigilance-Driven Cheminformatics Study. [PDF]
Uesawa Y, Inden K, Asada M.
europepmc +1 more source
Risk of drug-related aggression in pediatric populations: a pharmacovigilance analysis using the FAERS database. [PDF]
Chen J, Zhao L.
europepmc +1 more source
Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases. [PDF]
Qian Z, Jiang N.
europepmc +1 more source
The real-world safety evaluation of the selective NaV1.8 inhibitor suzetrigine: disproportionality analysis and flexible empirical bayes signals from FAERS with external triangulation. [PDF]
Lai K +6 more
europepmc +1 more source
Identification of Drug Associated Factors for Gingival Disorders: A Real-World Pharmacovigilance Study. [PDF]
Xiao Q, Wang C, Yang C.
europepmc +1 more source
A real-world pharmacovigilance study of romidepsin based on FDA adverse event reporting system database. [PDF]
Yang Y +5 more
europepmc +1 more source
Identification of drug-related cardiovascular risks: A comprehensive analysis using the FAERS database (2004-2024). [PDF]
Qin N +8 more
europepmc +1 more source
Pharmacovigilance analysis and real-world adverse event profile (safety signals and product-related issues) of potassium citrate: a US FDA adverse event reporting system (FAERS) based analysis. [PDF]
Ergül RB +14 more
europepmc +1 more source
Evaluating adverse reaction signals of vancomycin in pediatric patients: A FAERS database analysis. [PDF]
Li X, Zhang C, Hou J.
europepmc +1 more source

